financetom
Business
financetom
/
Business
/
Brazil's Itau hikes net interest income outlook, posts recurring profit in line with forecasts
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Brazil's Itau hikes net interest income outlook, posts recurring profit in line with forecasts
Nov 4, 2025 4:49 PM

SAO PAULO, Nov 4 (Reuters) - Brazilian lender Itau

Unibanco ( ITUB ) on Tuesday reported third-quarter net

recurring profit in line with analysts' estimates and raised its

projection for 2025 net interest income with the market.

Itau, Latin America's largest private lender by total

assets, reported an 11.9 billion reais ($2.20 billion) net

recurring profit for the July-September period, matching the

expectations of analysts polled by LSEG.

Return on equity stood at 23.3%, increasing 0.6 percentage

points from the same period a year earlier, but stable from the

previous quarter.

"Once again, the bank demonstrated its capacity to maintain

an already high profitability," Citi analysts led by Gustavo

Schroden wrote to clients, noting an "overall solid bottom

line."

The lender revised upward its yearly projection for net

interest income with the market to between 3 billion reais

($555.2 million) and 3.5 billion reais ($647.7 million), from a

previous estimate of between 1 billion and 3 billion reais.

"This revision mostly reflects the more positive dynamics of

the trading desk's accumulated results compared to the original

expectation," Itau said, adding all other 2025 projections

remain unchanged.

Itau's total credit portfolio reached 1.4 trillion reais in

the quarter, rising 6.4% year-on-year, while Itau's net interest

income increased 10.1% to 31.4 billion reais.

The over-90-day delinquency rate came in at 1.9%, stable

quarter-on-quarter, while the rate between 15 and 90 days rose

0.3 percentage points to 2%, with Itau citing the impact of an

unnamed large client.

Itau has not been releasing the year-over-year

comparison for delinquency rates following a regulatory change

on provisions that took effect in Brazil in January.

Itau's rivals Santander Brasil and Bradesco

released

their

third-quarter earnings last week, while Banco do Brasil

and Nubank are set to publish results next

week.

($1 = 5.4039 reais)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
TPG acquires minority stake in wealth management firm Creative Planning
TPG acquires minority stake in wealth management firm Creative Planning
Sep 30, 2024
Sept 30 (Reuters) - Asset manager TPG has bought a minority stake in wealth management firm Creative Planning, striking its second such deal in less than a week as it looks to expand its foothold in the investment advisory space. The deal, disclosed on Monday, comes days after Reuters reported that TPG was a frontrunner to pick up a $2...
Kezar Life Sciences pauses trial for lupus treatment after patient deaths
Kezar Life Sciences pauses trial for lupus treatment after patient deaths
Sep 30, 2024
Sept 30 (Reuters) - Kezar Life Sciences ( KZR ) said on Monday it has paused a trial of its experimental drug for lupus to review safety data after four patients died in the mid-stage study. The San Francisco-based company said it had informed the U.S. Food and Drug Administration and European regulators of the decision to pause enrollment and...
TPG acquires minority stake in wealth management firm Creative Planning
TPG acquires minority stake in wealth management firm Creative Planning
Sep 30, 2024
(Reuters) -Asset manager TPG has bought a minority stake in wealth management firm Creative Planning, striking its second such deal in less than a week as it looks to expand its foothold in the investment advisory space. The deal, disclosed on Monday, comes days after Reuters reported that TPG was a frontrunner to pick up a $2 billion stake in...
Microbot Medical Says it Expects to Finish its ACCESS-PVI Robotic Surgical System Clinical Trial Ahead of Schedule
Microbot Medical Says it Expects to Finish its ACCESS-PVI Robotic Surgical System Clinical Trial Ahead of Schedule
Sep 30, 2024
10:29 AM EDT, 09/30/2024 (MT Newswires) -- Microbot Medical ( MBOT ) said Monday its expects to finish its ACCESS-PVI clinical trial ahead of schedule, and remains on track to file its 510(k) premarket medical device submission with the US Food and Drug Administration by the end of the year. With 80% of patients having completed follow-ups, Microbot's ACCESS-PVI clinical...
Copyright 2023-2026 - www.financetom.com All Rights Reserved